Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-15-011953)

Filing Details

Accession Number:: 0001179110-15-011953
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-11 06:32:39
Reporting Period:: 2015-08-10

Filing Date:: 2015-08-11
Accepted Time:: 2015-08-11 06:32:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1360886	Osiris Therapeutics Inc.	OSIR	Biological Products, (No Disgnostic Substances) (2836)	710881115

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1636236	Alla Danilkovitch	C/O Osiris Therapeutics, Inc. 7015 Albert Einstein Drive Columbia MD 21046-1707	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-08-10	5,000	$0.40	10,375	No	4	M	Direct
Common Stock	Disposition	2015-08-10	2,425	$18.22	7,950	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-08-10	5,000	$0.40	5,000	$0.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
93,000	2006-12-01	2015-12-01	No	4	M	Direct

Footnotes

Represents the same-day sale exercise of non-qualified stock options granted under our Amended and Restated 1994 Stock Incentive Plan, whereby 5,000 options were exercised and 2,425 shares were concurrently retired to pay the exercise cost and taxes on the related gain, resulting in the net issuance of 2,575 shares of common stock.